Perkins' Pulmonx Raises Round

Rodney Perkins’ COPD company Pulmonx Inc. closed on a $20 million Series B financing, according to VentureWire Lifescience. Investors include New investors De Novo Ventures, which lead the round, Latterell Venture Partners and earlier investors Montreux Equity Partners and MedVenture Associates. For our comprehensive look at the COPD device space go here, and if you’d like the read more about Perkins check this piece.